Dramatic Regression of Chronic Lymphocytic Leukemia in the First Patient Treated With Donor-Derived Genetically-Engineered Anti-CD19-Chimeric-Antigen-Receptor-Expressing T Cells After Allogeneic Hematopoietic Stem Cell Transplantation

Saved in:
Bibliographic Details
Published in:Biology of blood and marrow transplantation 2011, Vol.17 (2), p.S158-S158
Main Authors: Kochenderfer, J.N, Dudley, M.E, Maric, I, Feldman, S.A, Salit, R, Hardy, N.M, Layton, P, Blacklock-Schuver, B, Wilder, J, Devillier, L, Gress, R.E, Morgan, R.A, Rosenberg, S.A, Bishop, M.R
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2010.12.025